Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Heart Failure V: Medical Management01:30

Heart Failure V: Medical Management

49
Medical Management of Acute Decompensated Heart Failure (ADHF)The primary goals of therapy for patients hospitalized with acute decompensated heart failure (ADHF) include:Relieving symptomsOptimizing volume statusSupporting oxygenation and ventilationMaintaining cardiac output (CO) and end-organ perfusionIdentifying and addressing the cause of ADHFPreventing complicationsProviding patient education on factors precipitating HF exacerbationPlanning for dischargeOngoing monitoring and assessment...
49
Dysrhythmias VII: Nursing Management of Dysrhythmias01:25

Dysrhythmias VII: Nursing Management of Dysrhythmias

139
Nursing management of dysrhythmias involves the following:AssessmentSubjective Assessment:The initial step involves gathering patient-reported symptoms such as dizziness, palpitations, and chest discomfort. It is crucial to collect a detailed history, including previous heart conditions, current medication use, and lifestyle factors like caffeine and alcohol consumption.Objective Assessment:This involves observing clinical signs such as jugular venous distention, cool and pale skin, and...
139
Cardiopulmonary Resuscitation IV: Pharmacological Management01:25

Cardiopulmonary Resuscitation IV: Pharmacological Management

113
Pharmacologic intervention is crucial in treating cardiac arrest patients during ACLS or Advanced Cardiovascular Life Support. The ACLS algorithms guide the administration of specific drugs based on the patient's cardiac arrest rhythm, which includes pulseless ventricular tachycardia (VT), ventricular fibrillation (VF), asystole, and pulseless electrical activity (PEA).EpinephrineIndication: Epinephrine is the first-line drug for all cardiac arrest rhythms.Mechanism of Action: Epinephrine...
113
Dysrhythmias VI: Management of Dysrhythmias01:25

Dysrhythmias VI: Management of Dysrhythmias

153
Dysrhythmia management involves a multifaceted approach, incorporating pharmacological treatments, medical procedures, surgical interventions, lifestyle modifications, and patient education.Pharmacological ManagementAntiarrhythmic Drugs:Class I (Sodium Channel Blockers): This class includes quinidine and procainamide, which reduce the speed of impulse conduction in the heart, stabilize the cardiac membrane, and control arrhythmias. Quinidine and procainamide are Class IA agents that prolong the...
153
Cardiomyopathy VI: Nursing Management01:29

Cardiomyopathy VI: Nursing Management

76
Assessment: Nursing management of patients with cardiomyopathy begins with a thorough assessment of the patient's history, including a family history of cardiomyopathy or sudden cardiac death, personal history of heart disease, hypertension, diabetes, and any alcohol consumption or drug use.During the physical examination, assess vital signs, look for signs of heart failure (such as edema, jugular venous distention, and cyanosis), auscultate for abnormal heart sounds (like murmurs and gallops),...
76
Angina IV: Management01:26

Angina IV: Management

48
IntroductionThe management of angina requires a comprehensive approach that includes pharmacological therapies, medical procedures, and lifestyle modifications.Pharmacological TherapiesAntiplatelet agents, such as aspirin, clopidogrel, prasugrel, and ticagrelor, play a pivotal role in preventing thrombus formation in patients with angina. These medications inhibit platelet aggregation and reduce the likelihood of myocardial infarction and other cardiovascular events.Anticoagulants, including...
48

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Development of decision support framework to prioritize GHG emission Scope in sub-national inventories.

iScience·2026
Same author

Epitope-spanning antigenic variation reprograms immunodominance and broadens immunity in sequential influenza vaccination.

Nature communications·2026
Same author

The Impact of Chronic Kidney Disease on In-Hospital Outcomes in Patients With Acute Respiratory Distress Syndrome.

Canadian respiratory journal·2026
Same author

Atrial fibrillation in patients with obesity: How can we optimize management?

Cleveland Clinic journal of medicine·2026
Same author

K<sub>V</sub> channel antagonism blunts vasodilatation in skeletal muscle of humans.

The Journal of physiology·2025
Same author

Evaluating outcomes in critically ill patients with undiagnosed acute kidney injury: a comparison of the incidence of physician-diagnosed vs KDIGO criteria-diagnosed acute kidney injury.

Proceedings (Baylor University. Medical Center)·2025

Related Experiment Video

Updated: Oct 14, 2025

Tilt Testing with Combined Lower Body Negative Pressure: a "Gold Standard" for Measuring Orthostatic Tolerance
14:09

Tilt Testing with Combined Lower Body Negative Pressure: a "Gold Standard" for Measuring Orthostatic Tolerance

Published on: March 21, 2013

21.0K

Management strategies for vasovagal syncope.

Muzaffar Ali1, Jose Carlos Pachon Maetos2, Asim Kichloo3,4

  • 1Sheri Kashmir Institute, Department of Cardiology, Srinagar, Jammu and Kashmir, India.

Pacing and Clinical Electrophysiology : PACE
|November 8, 2021
PubMed
Summary

Vasovagal syncope (VVS) is a common condition causing injury and distress. This article reviews management, focusing on advanced treatments like closed loop stimulation (CLS) and cardioneuroablation (CNA).

Keywords:
cardioneuroablation (CNA)dysautonomiasyncopevasovagal syncope (VVS)

More Related Videos

Software for Analysis of Heart Rate and Blood Pressure Time-series Data from the Valsalva Maneuver
14:28

Software for Analysis of Heart Rate and Blood Pressure Time-series Data from the Valsalva Maneuver

Published on: June 27, 2025

498
Transauricular Vagus Nerve Stimulation and Electroencephalographic Assessment in Disorders of Consciousness
04:04

Transauricular Vagus Nerve Stimulation and Electroencephalographic Assessment in Disorders of Consciousness

Published on: July 11, 2025

522

Related Experiment Videos

Last Updated: Oct 14, 2025

Tilt Testing with Combined Lower Body Negative Pressure: a "Gold Standard" for Measuring Orthostatic Tolerance
14:09

Tilt Testing with Combined Lower Body Negative Pressure: a "Gold Standard" for Measuring Orthostatic Tolerance

Published on: March 21, 2013

21.0K
Software for Analysis of Heart Rate and Blood Pressure Time-series Data from the Valsalva Maneuver
14:28

Software for Analysis of Heart Rate and Blood Pressure Time-series Data from the Valsalva Maneuver

Published on: June 27, 2025

498
Transauricular Vagus Nerve Stimulation and Electroencephalographic Assessment in Disorders of Consciousness
04:04

Transauricular Vagus Nerve Stimulation and Electroencephalographic Assessment in Disorders of Consciousness

Published on: July 11, 2025

522

Area of Science:

  • Cardiology
  • Neurology
  • Medical Devices

Background:

  • Vasovagal syncope (VVS), also known as neurocardiogenic syncope, is a prevalent clinical challenge.
  • Recurrent VVS episodes can lead to significant physical harm and psychological distress for patients.

Purpose of the Study:

  • To provide a concise overview of current VVS management strategies.
  • To detail advanced therapeutic options, specifically closed loop stimulation (CLS) and cardioneuroablation (CNA).

Main Methods:

  • Literature review of existing VVS management protocols.
  • Detailed examination of the mechanisms and application of CLS and CNA.

Main Results:

  • Current management strategies for VVS are discussed.
  • Therapeutic modalities including CLS and CNA are explored in detail.

Conclusions:

  • VVS presents significant challenges for both patients and physicians.
  • CLS and CNA represent promising therapeutic avenues for managing recurrent VVS.